PharmaLex, a provider of specialised services for the pharma, biotech and MedTech industries worldwide, agreed  to merge with NeoHealthHub, a UK-based pharmaceutical and healthcare services consultancy. Financial terms were not disclosed. “The merger is a good strategic fit for NHH because we share similar values and corporate culture with PharmaLex, built on an entrepreneurial spirit. Both our organisations support a model of thinking global but acting local, which for us means responding to the unique and complex needs of the pharmaceutical and healthcare marketplace. We have created an organisation and structure that allows us to operate in a truly agile way, maximising opportunities as they emerge. Through the merger, we will be able to build on those opportunities and offer extended services and expertise to our clients, while further expanding the client base," Simon Doyle, NHH CEO.